Sharemaestro Newsreel

AI company BullFrog AI sets online investor meetings for July 29

BullFrog AI (NASDAQ: BFRG) announced that its management team will participate in the BTIG Virtual Biotechnology Conference on July 28-29, 2026. The company will hold one-on-one investor meetings on July 29, 2026. BullFrog AI uses artificial intelligence and machine learning to advance pharmaceutical R&D …

BullFrog AI to join BTIG Virtual Biotechnology Conference for investor meetings on July 29, 2026

BullFrog AI Holdings, an AI-driven biomedical data company, announced its participation in the BTIG Virtual Biotechnology Conference on July 28-29, 2026. The company's management will hold one-on-one investor meetings on July 29 to discuss their AI-powered pharmaceutical R&D and drug discovery platform. This event …

BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026

BullFrog AI Holdings, Inc. announced that its Founder and CEO, Vin Singh, will participate in a Water Tower Research Fireside Chat on Thursday, July 23, 2026, at 1:00 pm ET. The discussion will cover BullFrog AI's value proposition, its AI platform originating from Johns …

Waystar Holding Corp. $WAY Shares Sold by Jennison Associates LLC

Jennison Associates LLC significantly reduced its stake in Waystar Holding Corp. by 41.5% in the first quarter, selling 366,681 shares. Despite this, Waystar reported stronger-than-expected Q1 earnings with $0.42 EPS and $313.87 million in revenue, leading to a "Moderate Buy" consensus rating from Wall …

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT) and Tempus AI, Inc. Class A (TEM)

This article provides an overview of recent analyst ratings for two healthcare companies: 4D Molecular Therapeutics (FDMT) and Tempus AI, Inc. Class A (TEM). Bank of America Securities maintained a Buy rating on 4D Molecular Therapeutics, citing a strong upside potential. William Blair assigned …

WEAV Q1 2026 Earnings: EPS Beat Fails to Lift Stock as Revenue Data Unavailable - EPS Surprise History

Royce & Associates (OPRX) discloses 1.09M-share passive stake in OptimizeRx

Royce & Associates, LP has disclosed a passive stake of 1,089,398 shares in OptimizeRx Corp (OPRX), representing 5.81% of the company's common stock as of June 30, 2026. Royce & Associates, an indirect majority-owned subsidiary of Franklin Resources, Inc., holds this position for its …

Spok Sets Date to Report Second Quarter 2026 Results

Spok Holdings, Inc. (NASDAQ: SPOK) announced it will release its second quarter 2026 operating results on Wednesday, July 29, 2026, after the close of U.S. financial markets. The company will host a conference call and webcast to discuss these results at 5:00 p.m. ET …

VSee Health proposes 80-for-1 reverse stock split to retain listing

VSee Health, Inc. has announced a proposed reverse stock split of up to 80-for-1 to maintain its Nasdaq listing. This decision, which is subject to shareholder and regulatory approval, follows the termination of a previous equity purchase agreement and a reduction from an earlier …

Phreesia Launches AI Chatbot to Connect Patients With Healthcare Providers

Phreesia has launched an AI-powered chatbot designed to streamline patient-provider connections. The new tool aims to improve the healthcare experience by facilitating easier access and communication. This development highlights Phreesia's ongoing efforts to integrate advanced technology into its platform to enhance patient engagement.

VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution

VSee Health, Inc. has reaffirmed its commitment to minimizing shareholder dilution and maintaining its Nasdaq listing. The company announced a proposed maximum 80-for-1 reverse stock split, significantly reduced from a previously considered 250-to-1 ratio, and confirmed the termination of a standby equity purchase agreement. …

VSee Health Terminates Equity Agreement; No Near-Term Dilution Expected

VSee Health (NASDAQ:VSEE) announced the termination of its standby equity purchase agreement, eliminating expectations of near-term dilution, and reaffirmed its commitment to minimizing shareholder dilution. The company's board also approved a proposed reverse stock split of up to 80-for-1, down from a previously referenced …

DarioHealth Plans About $23.5M Stock Sale for Acquisitions

DarioHealth (NASDAQ: DRIO) announced a registered direct offering of 3,454,559 shares at $6.80 each, expected to raise approximately $23.5 million in gross proceeds. The offering, priced at-the-market under Nasdaq rules, includes participation from existing institutional investors, a new global investor, and a board member. …

Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

DarioHealth Corp. announced the pricing of a $23.5 million registered direct offering of common stock at $6.80 per share, priced at-the-market under Nasdaq rules. The offering sees continued support from existing long-term institutional investors and participation from new fundamental investors, including a member of …

HC Wainwright Estimates SOPHiA GENETICS Q2 Earnings

HC Wainwright has reiterated a "Buy" rating and a $12.00 price target for SOPHiA GENETICS (NASDAQ:SOPH), estimating a Q2 2026 loss of $0.15 per share. The firm projects profitability for SOPHiA GENETICS by FY2028. Despite missing Q2 2026 EPS expectations at $(0.27), the company …

Waystar Holding (WAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Waystar Holding (WAY) is anticipated to report increased earnings and higher revenues for the quarter ended June 2026, with an expected earnings report release on July 29. The Zacks Consensus Estimate projects earnings per share (EPS) of $0.40, a +11.1% year-over-year change, and revenues …

American Well Corporation (NYSE:AMWL) Given Consensus Recommendation of "Hold" by Analysts

American Well Corporation (NYSE:AMWL) has received a consensus "Hold" rating from analysts, with an average 12-month target price of $8.60. While some analysts, like Wells Fargo, have issued "Overweight" ratings and increased price targets, others, including Weiss Ratings, have reiterated "Sell" recommendations. Insider selling …

Spok (SPOK) Expected to Post Earnings on Wednesday

Spok (NASDAQ:SPOK) is expected to release its Q2 2026 earnings after market close on Wednesday, July 29th, with analysts projecting $0.15 EPS and $34.30 million in revenue. The company recently paid a quarterly dividend of $0.3125, resulting in an annualized yield of 11.7%, and …

Fifth Third Bancorp Has $2.11 Million Stake in HealthEquity, Inc. $HQY

Fifth Third Bancorp significantly increased its stake in HealthEquity, Inc. (NASDAQ:HQY) by 2,370.6% in the first quarter, now owning 25,200 shares worth $2.11 million. Several other institutional investors also adjusted their positions in HQY, and analysts have issued new price targets, resulting in a …

Why (WEAV) Price Action Is Critical for Tactical Trading

The article analyzes Weave Communications Inc. (NASDAQ: WEAV) focusing on its price action and tactical trading strategies. It highlights current weak sentiment but notes no resistance levels above the current price, suggesting upside potential. AI models have generated position, momentum breakout, and risk hedging …

CCORF Maintains Teladoc Health(TDOC.US) With Buy Rating, Raises Target Price to $11

CCORF has reiterated its Buy rating for Teladoc Health (TDOC.US) and increased its target price to $11. This indicates continued confidence in the company's performance and future prospects.

Omnicell (OMCL) Stock Forum and Discussion

This article provides a forum for discussion regarding Omnicell (OMCL) stock. It includes a basic stock quote for OMCL, showing its last price, change, and percentage change. The article encourages users to share their opinions and insights on Omnicell's future performance.

Waystar Earns Overall "A" Rating from KLAS for Revenue Cycle Suites, Cementing Its Platform Advantage in a Fragmented Market

Waystar received an overall "A" satisfaction score from KLAS Research for its revenue cycle management (RCM) platform, as highlighted in the inaugural Revenue Cycle Management Suites 2026 report. The study focused on "deep adopters" using multiple Waystar RCM solutions, finding that these healthcare organizations …

Lobbying Update: $100,000 of HEARTFLOW INC. lobbying was just disclosed

HeartFlow Inc. recently disclosed $100,000 in lobbying expenditures for Q2 2026, focusing on issues related to physician payments, Medicare reimbursement for AI-enabled technology, and specific health legislation. Concurrently, HTFL insiders have exclusively sold shares over the past six months, while institutional investors show mixed …

Do Softer Earnings Expectations Undermine Or Validate Teladoc’s Virtual Care Thesis And Transition Story (TDOC)?

Teladoc Health (NYSE:TDOC) is facing softer earnings expectations for its upcoming Q3 2026 earnings release, with analysts projecting a fall in EPS and revenue compared to the prior year. Despite this, analyst sentiment remains positive, focusing on the long-term value of Teladoc's virtual care …

Evolent Health Inc Class A (EVH) Stock Price | Live Quotes & Charts | NYSE

This page provides live stock quotes and charts for Evolent Health Inc Class A (EVH) on the NYSE, showing a current price of $4.26 and an 8.19% decrease. It also notes the absence of analyst ratings or earnings information for the company. The page …

SOPHiA GENETICS (SOPH) affiliate files to sell 37,000 founders shares on NASDAQ

SOPHiA GENETICS (SOPH) has announced that an affiliate, through Morgan Stanley Smith Barney LLC Executive Financial Services, has filed to sell up to 37,000 founders shares on NASDAQ, valued at $234,210.00. The SEC filing also details previous sales by Jurgi Camblong under a Rule …

Fitch upgrades Waystar rating on lower leverage expectations

Fitch Ratings upgraded Waystar Holding Corp. (NYSE:WAY) to 'BB+' from 'BB' for its Long-Term Issuer Default Rating, and its first lien term loan to 'BBB-' from 'BB+'/ 'RR2'. This upgrade is due to lower leverage expectations, with Fitch-adjusted EBITDA leverage projected to decline below …

Tempus AI buys Personalis for $1.5 billion

Tempus AI has agreed to acquire Personalis for $1.5 billion, or $16.25 per share, to integrate Personalis' cancer-monitoring technology into its precision-oncology platform. The deal, which allows Tempus to pay up to 50% in cash, is anticipated to close in late 2026 or early …

ETFs Investing in Tempus AI, Inc. Class A Stocks

This article lists various ETFs that currently hold Tempus AI, Inc. Class A stocks, sorted by market value. It provides key details for each ETF, such as their market value, weight of Tempus AI stock, issuer, management style, focus, expense ratio, assets under management …

Omnicell to Report Q2 Earnings: OmniSphere in Focus

Omnicell (OMCL) is scheduled to release its second-quarter 2026 earnings on July 30, with expectations for revenue growth to reach $309.6 million and earnings per share of 48 cents. The company's performance is anticipated to be driven by its Connected Devices strategy, expanding recurring …

Impax Asset Management Group (HCAT) discloses 4M-share position in Health Catalyst

Impax Asset Management Group plc has disclosed a beneficial ownership of 4,000,000 shares of Health Catalyst, Inc. common stock, representing 5.41% of the class. This filing indicates that Impax Asset Management LLC, a wholly-owned subsidiary, retains sole voting and dispositive power over these shares. …

ETFs Investing in Talkspace, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Talkspace, Inc. (TALK). It provides a detailed table including each fund's market value, weight of TALK stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, …

Schrodinger, Inc. $SDGR Shares Purchased by Amova Asset Management Americas Inc.

Amova Asset Management Americas Inc. increased its stake in Schrodinger, Inc. ($SDGR) by 13.2% in the first quarter, bringing its total holdings to 3.19 million shares worth approximately $36.2 million. Despite a wider-than-expected quarterly loss, Schrodinger's revenue exceeded analyst estimates. The stock currently holds …

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026

SOPHiA GENETICS announced that it will release its financial results for the second quarter of 2026 before U.S. markets open on Tuesday, August 4, 2026. The company will also host a conference call on the same day at 8:00 a.m. EDT / 2:00 p.m. …

How Spok Holdings Inc. (SPOK) Affects Rotational Strategy Timing

This article analyzes Spok Holdings Inc. (SPOK) to determine its impact on rotational strategy timing, highlighting a positive near-term sentiment that may shift. It outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, along …